UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 239

Sortiert nach

Early Evidence on the Effects of Regulators' Suicidality Warnings on SSRI Prescriptions and Suicide in Children and Adolescents

The American journal of psychiatry, 2007-09, Vol.164 (9), p.1356-1363

2007

Volltextzugriff (PDF)

Psoriasis May Not be an Independent Risk Factor for Acute Ischemic Heart Disease Hospitalizations: Results of a Large Population-Based Dutch Cohort

Journal of investigative dermatology, 2010-04, Vol.130 (4), p.962-967

2010

Volltextzugriff (PDF)

Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives: Results from a large population-based follow-up study

Diabetes care, 2012-01, Vol.35 (1), p.119-124

2012

Volltextzugriff (PDF)

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries

PloS one, 2024-03, Vol.19 (3), p.e0298596-e0298596

2024

Volltextzugriff (PDF)

Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-Based Multi-Database Study

Clinical therapeutics, 2017-04, Vol.39 (4), p.759-770

2017

Volltextzugriff (PDF)

How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study

Diabetes, obesity & metabolism, 2019-04, Vol.21 (4), p.968-974

2019

Volltextzugriff (PDF)

Statin Use After Diagnosis of Colon Cancer and Patient Survival

Gastroenterology (New York, N.Y. 1943), 2017-08, Vol.153 (2), p.470-479.e4

2017

Volltextzugriff (PDF)

Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe

The American journal of medicine, 2009-02, Vol.122 (2), p.S3-S13

2009

Volltextzugriff (PDF)

Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis

Breast cancer research and treatment, 2010-08, Vol.122 (3), p.843-851

2010

Volltextzugriff (PDF)

Existing Data Sources for Clinical Epidemiology: The PHARMO Database Network

Clinical epidemiology, 2020-01, Vol.12, p.415-422

2020

Volltextzugriff (PDF)

Use of Lipid-Modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands

Clinical therapeutics, 2017-04, Vol.39 (4), p.819-827.e1

2017

Volltextzugriff (PDF)

Risk of dipeptidyl peptidase‐4 (DPP‐4) inhibitors on site‐specific cancer: A systematic review and meta‐analysis

Diabetes/metabolism research and reviews, 2018-07, Vol.34 (5), p.e3004-n/a

2018

Volltextzugriff (PDF)

Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting

Diabetologia, 2020-06, Vol.63 (6), p.1110-1119

2020

Volltextzugriff (PDF)

Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands

Respiratory research, 2023-11, Vol.24 (1), p.1-293, Article 293

2023

Volltextzugriff (PDF)

New opportunities for drug outcomes research in cancer patients: The linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System

European journal of cancer (1990), 2010-01, Vol.46 (2), p.395-404

2010

Volltextzugriff (PDF)

Type 2 Diabetes, the Epidemic: Trends in Prevalence and Incidence, 2004-2020

Diabetes, metabolic syndrome and obesity, 2024-01, Vol.17, p.1503-1509

2024

Volltextzugriff (PDF)

Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998-2010

European heart journal, 2013-11, Vol.34 (41), p.3198-3205

2013

Volltextzugriff (PDF)

Completeness and Representativeness of the PHARMO General Practitioner (GP) Data: A Comparison with National Statistics

Clinical epidemiology, 2023-01, Vol.15, p.1-11

2023

Volltextzugriff (PDF)

Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study

European heart journal, 2007-01, Vol.28 (2), p.154-159

2007

Volltextzugriff (PDF)

Impact of implementing Dutch versus European guideline risk factor targets in older patients with ischaemic heart disease

Netherlands heart journal, 2024-01, Vol.32 (1), p.45-54

2024

Volltextzugriff (PDF)

Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes

International journal of colorectal disease, 2019-02, Vol.34 (2), p.269-276

2019

Volltextzugriff (PDF)

Type 2 Diabetes, but Not Insulin (Analog) Treatment, Is Associated With More Advanced Stages of Breast Cancer: A National Linkage of Cancer and Pharmacy Registries

Diabetes care, 2019-03, Vol.42 (3), p.434-442

2019

Volltextzugriff (PDF)

Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources

The Lancet regional health. Europe, 2022-02, Vol.13, p.100266-100266, Article 100266

2022

Volltextzugriff (PDF)

Dutch trends in the use of potentially harmful medication during pregnancy

British journal of clinical pharmacology, 2020-12, Vol.86 (12), p.2377-2392

2020

Volltextzugriff (PDF)

Incident cancer risk after the start of aspirin use: Results from a Dutch population‐based cohort study of low dose aspirin users

International journal of cancer, 2014-07, Vol.135 (1), p.157-165

2014

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(205)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(183)
Life Sciences & Biomedicine
(178)
Humans
(153)
Female
(111)
Middle Aged
(99)
Male
(95)
Aged
(88)
Adult
(69)
Pharmacology & Pharmacy
(69)
Biological And Medical Sciences
(53)
Medical Sciences
(53)
Netherlands
(50)
Cohort Studies
(46)
Risk Factors
(46)
Public, Environmental & Occupational Health
(40)
Retrospective Studies
(33)
Aged, 80 And Over
(32)
Netherlands - Epidemiology
(32)
Pharmacology. Drug Treatments
(32)
General & Internal Medicine
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Early Evidence on the Effects of Regulators' Suicidality Warnings on SSRI Prescriptions and Suicide in Children and Adolescents

Psoriasis May Not be an Independent Risk Factor for Acute Ischemic Heart Disease Hospitalizations: Results of a Large Population-Based Dutch Cohort

Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives: Results from a large population-based follow-up study

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries

Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-Based Multi-Database Study

How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study

Statin Use After Diagnosis of Colon Cancer and Patient Survival

Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe

Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis

Existing Data Sources for Clinical Epidemiology: The PHARMO Database Network

Use of Lipid-Modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands

Risk of dipeptidyl peptidase‐4 (DPP‐4) inhibitors on site‐specific cancer: A systematic review and meta‐analysis

Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting

Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands

New opportunities for drug outcomes research in cancer patients: The linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System

Type 2 Diabetes, the Epidemic: Trends in Prevalence and Incidence, 2004-2020

Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998-2010

Completeness and Representativeness of the PHARMO General Practitioner (GP) Data: A Comparison with National Statistics

Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study

Impact of implementing Dutch versus European guideline risk factor targets in older patients with ischaemic heart disease

Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes

Type 2 Diabetes, but Not Insulin (Analog) Treatment, Is Associated With More Advanced Stages of Breast Cancer: A National Linkage of Cancer and Pharmacy Registries

Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources

Dutch trends in the use of potentially harmful medication during pregnancy

Incident cancer risk after the start of aspirin use: Results from a Dutch population‐based cohort study of low dose aspirin users

Suchergebnisse filtern